This article is more than 5 years old. Information may no longer be current.

CIBA, J&J in patent dispute

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA — CIBA Vision has filed suit against Vistakon for allegedly infringing upon CIBA’s patented silicone hydrogel contact lens technology. CIBA seeks to halt a planned launch of a Johnson & Johnson silicone hydrogel extended wear contact lens, according to a CIBA press release. J&J notes this suit is in response to one filed by J&J in February.

The CIBA patents, deemed the “Nicolson” patents, cover CIBA’s Night & Day and O2Optix breathable contact lens technology, the company asserted. According to a J&J spokesperson, Johnson & Johnson Vision Care filed a lawsuit on February 8, 2005 against CIBA for a judgment that its Acuvue Oasys, J&J's newest silicone hydrogel lenses, do not infringe any valid CIBA patent.

“These patents were the subject of protracted global litigation with Bausch & Lomb that resulted in a 2004 license granted to B&L in exchange for a royalty payable to CIBA through 2014 in the U.S. and 2016 in other countries,” CIBA's release noted.

Vistakon is a division of Johnson & Johnson. CIBA has requested the District Court in Florida prevent J&J/Vistakon from manufacturing, marketing and distributing the lenses.